Accentus Medical is pleased to announce the launch of its manufacturing capability for commercial supply of Agluna® anti-microbial surface technology for titanium medical implants.
Category: Company Updates
Agluna® Treated Devices Significantly Reduce Infection Rates
Accentus Medical is pleased to announce the results of a retrospective review of near-term post-operative infection rates associated with orthopaedic limb salvage devices treated with its innovative Agluna® surface technology.
Accentus Medical Announces Completion of Management Buyout
Accentus Medical has announced today the successful completion of a management buyout.
Accentus Medical Strengthens Board of Directors to Support Growth Drive
Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of Brian Howlett and Laurie Rostron to its board of directors.
Acusure® Technology gains further approval for use in the USA
Accentus Medical is pleased to announce that one of its customers, FHi, a member of the FH Orthopedics Group, recently gained a 510(K) approval from the US Food and Drug Administration for its Arrow Reverse Total Shoulder prosthesis. This product incorporates the proprietary Acusure® inert gas plasma spray coating, applied by Accentus Medical at our facility in Harwell.